Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy
Multiple patients have survived substantially beyond expected median survival, including onepatient who survived 28 months and several patients…